ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 3

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. The Different Mechanisms of Cancer Drug Resistance: A Brief Review

Behzad Mansoori, Ali Mohammadi, Sadaf Davudian, Solmaz Shirjang, Behzad Baradaran*

Adv Pharm Bull. 2017;7(3): 339-348. doi: 10.15171/apb.2017.041

PMCID: PMC5651054 PMID: 29071215 Scopus ID: 85030114747

Article

PDF

XML

Cited By:

651

451

1283

Review Article

2. Micromanaging Glucose Tolerance and Diabetes

Negar Saliani, Soheila Montazersaheb, Shideh Montasser Kouhsari*

Adv Pharm Bull. 2017;7(4): 547-556. doi: 10.15171/apb.2017.066

PMCID: PMC5788209 PMID: 29399544 Scopus ID: 85043384245

Article

PDF

XML

Cited By:

Short Communication

3. The Increased RNase Activity of IRE1α in PBMCs from Patients with Rheumatoid Arthritis

Mahdieh Ahmadiany, Mahshid Alavi-Samani, Zahra Hashemi, Mohammad Amin Moosavi , Marveh Rahmati*

Adv Pharm Bull. 2019;9(3): 505-509. doi: 10.15171/apb.2019.060

PMCID: PMC6773928 PMID: 31592115 Scopus ID: 85070448366

Article

PDF

XML

Cited By:

Research Article

4. Up-Regulation of Cell-Free MicroRNA-1 and MicroRNA-221-3p Levels in Patients with Myocardial Infarction Undergoing Coronary Angiography

Fatemeh Mansouri* , Mir hosein Seyed Mohammadzad

Adv Pharm Bull. 2021;11(4): 719-727. doi: 10.34172/apb.2021.081

PMCID: PMC8642802 PMID: 34888219 Scopus ID: 85117274143

Article

PDF

Full Text

XML

Cited By:

Research Article

5. MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study

Leila Tebbi , Behzad Mansoori, Sahar Safaei, Shahriar Hashemzadeh, Masoud Shirmohamadi, Khalil Hajiasgharzadeh, Mahdi Abdoli Shadbad, Behzad Baradaran*

Adv Pharm Bull. 2022;12(4): 842-849. doi: 10.34172/apb.2022.083

PMCID: PMC9675915 PMID: 36415628 Scopus ID: 85140272177

Article

PDF

Full Text

XML

Cited By:

Research Article

6. The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro

Monireh Khordadmehr* , Reyhaneh Matin , Behzad Baradaran* , Elham Baghbani , Farinaz Jigari-Asl , Saeed Noorolyai

Adv Pharm Bull. 2023;13(2): 378-384. doi: 10.34172/apb.2023.041

PMCID: PMC10278211 PMID: 37342379

Article

PDF

Full Text

XML

Cited By:

Review Article

7. MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations

Behrouz Shademan , Vahidreza Karamad , Alireza Nourazarian, Sepideh Masjedi, Alireza Isazadeh, Fatma Sogutlu, Cigir Biray Avcı*

Adv Pharm Bull. 2023;13(3): 435-445. doi: 10.34172/apb.2023.047

PMCID: PMC10460809 PMID: 37646065

Article

PDF

Full Text

XML

Cited By:

Original Article

8. Continuous Uptake of MiR-181a-2 Mimetic Induces Constitutive Overexpression of Cellular MiR-181a-2 in MCF-7 Breast Cancer Cells: Links with Progression of Drug Resistance

Olga Evgen’evna Andreeva , Danila Vladimirovich Sorokin , Svetlana Vladimirovna Vinokurova , Pavel Borisovich Kopnin , Nadezhda Viacheslavovna Elkina , Danila Sergeevich Elkin , Maria Dmitrievna Fedorova , Alexander Mikhailovich Scherbakov* , Mikhail Aleksandrovich Krasil’nikov*

Adv Pharm Bull. 2025;15(3): 678-685. doi: 10.34172/apb.025.43440

Article

PDF

XML

Cited By:

Original Article

9. Silencing Calumenin Expression via Artificial MicroRNA, a Potential Breakthrough for Inhibiting Proliferation, Halting Migration, and Triggering Apoptosis in Breast Cancer Cells

Zahra Amiri , Fatemeh Bahrami, Babak Jahangiri , Arash Javeri, Frouzandeh Mahjoubi, Nahid Nafissi, Mohammad Zaefizadeh, Fatemeh Masoumi, Alireza Zomorodipour*

Adv Pharm Bull. 2025;15(2): 453-466. doi: 10.34172/apb.025.43819

PMCID: PMC12413967 PMID: 40922754

Article

PDF

XML

Cited By: